| Name | (S)-3,4-Dihydro-4-oxo-N-(1-phenylethyl)-2-quinazolinepropanamide |
|---|---|
| Synonyms | 3-(4-oxo-1H-quinazolin-2-yl)-N-[(1S)-1-phenylethyl]propanamide |
| Description | ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28 μM. |
|---|---|
| Related Catalog | |
| Target |
ARTD3/PARP3:0.89 μM (IC50) ARTD1/PARP1:6.3 μM (IC50) ARTD2/PARP2:10.8 μM (IC50) ARTD6/TNKS2:34.3 μM (IC50) ARTD5/TNKS1:47.3 μM (IC50) ARTD10/PARP10:71.3 μM (IC50) |
| In Vitro | ME0328 is a potent and selective inhibitor of ARTD3/PARP3 that is active in cells. In in vitro histone H1 modification assay, ME0328 inhibits the transferase activity of ARTD3 with an IC50 of 0.89±0.28 μM. In human A549 cells, ME0328 and ME0355 (at 10 μM) delay the resolution of γH2AX-containing foci that serve as markers for DNA double strand break repair following γ-irradiation (2 Gy). In silico and in vitro physicochemical and metabolic profiling indicated that ME0328 is soluble, cell permeable, and metabolically stable in human liver microsomes and rat hepatocytes[1]. |
| References |
| Molecular Formula | C19H19N3O2 |
|---|---|
| Molecular Weight | 321.37300 |
| Exact Mass | 321.14800 |
| PSA | 78.60000 |
| LogP | 3.98570 |
| Appearance | white to beige |
| Storage condition | room temp |
| Water Solubility | DMSO: soluble10mg/mL, clear |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| Risk Phrases | 22-43 |
| Safety Phrases | 36/37 |
| RIDADR | NONH for all modes of transport |